Skip to main content

Table 2 Descriptive statistics of the two cohorts (pre- and post- course) included in the study

From: Promoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship

  Pre-course (n = 15) Post-course (n = 15)
Age at diagnosis (years) 68 (59–72) 63 (59–70)
PSA at baseline MR (ng/ml) 7.75 (5.6–8.9) 6.04 (5.2–10.3)
Prostate volume at baseline MR (cc) 42.1 (37–56.2) 53.3 (32.7–80.3)
PSA density at baseline MR (ng/ml/ml) 0.16 (0.1–0.24) 0.13 (0.1–0.17)
Gleason score at entry biopsy
3 + 3 14 [93] 10 [67]
3 + 4 1 [7] 5 [22]
Gleason score at confirmatory biopsy
3 + 3 3 [20] 10 [67]
3 + 4 8 [53] 4 [26]
4 + 3 3 [20] 1 [7]
4 + 4 1 [7]
Baseline highest PI-RADS score
2 1 [7] 2 [13]
3 6 [40] 6 [40]
4 8 [53] 7 [47]
5
Follow up highest PI-RADS score
2 1 [7] 3 [20]
3 2 [13] 4 [26]
4 10 [67] 6 [40]
5 2 [13] 2 [14]
PRECISE score
1
2 1 [7]
3 2 [13] 10 [67]
4 10 [67] 4 [26]
5 2 [13] 1 [7]
  1. Data are medians and interquartile range (parentheses); percentages in brackets [%]
  2. PSA: Prostate Specific Antigen; MR: Magnetic Resonance; PI-RADS: Prostate Imaging–Reporting And Data System; PRECISE: Prostate Cancer Radiological Estimation of Change in Sequential Evaluation